Next Generation News and Research

RSS

National Institutes of Health names University of Rochester a Center for AIDS Research

The University of Rochester was named a Center for AIDS Research by the National Institutes of Health, a designation that infuses $7.5 million into HIV/AIDS work across the University and places it amongst the best in the nation for research to improve the prevention, detection and treatment of the disease.

10 May 2013

Convergent to discuss ways to enhance patient experience with healthcare leaders

meeting with healthcare leaders to discuss ways to improve their financial performance and enhance the patient experience while exhibiting at the Healthcare Financial Management Association's Annual National Institute June 16-19 in Orlando, FL.

9 May 2013

European Patent Office issues notice of intent to grant patent for Nuvo Research's PENNSAID 2%

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain today announced that the European Patent Office has issued a notice of Intention to Grant a European Patent that provides protection for the Company's PENNSAID 2% product.

9 May 2013

Columbia Laboratories net revenues increase 65% to $6.3 million in first quarter 2013

Columbia Laboratories, Inc. today reported financial results for the three-month period ended March 31, 2013.

9 May 2013

CGCF backs Canadian scientist's research on Spinal Muscular Atrophy

The Canadian Gene Cure Foundation, in partnership with the Canadian Institutes of Health Research through its Institute of Genetics, is pleased to announce the awarding of a $90,000 Champions of Genetics: Building the Next Generation Grant to Dr. Faraz Farooq, a Scientist at the Children Hospital of Eastern Ontario Research Institute.

9 May 2013

Study shows patient selection based on biosamples makes clinical trials more efficient, reduces costs

Researchers at Moffitt Cancer Center say identifying and selecting participants for phase II cancer clinical trials from a centralized warehouse of patient-donated biological data expedites participant accrual, reduces trial size, saves money, and may speed test drugs through the drug development pipeline.

8 May 2013

Elixir Medical receives FDA approval to initiate patient enrollment in EXCELLA III clinical trial in US

Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today that it has received approval from the Food and Drug Administration to initiate patient enrollment in the EXCELLA III clinical trial in the United States at up to 50 institutions with conditions to be addressed in parallel.

8 May 2013

Good Start Genetics gets $28M loan from Capital Royalty

Good Start Genetics, Inc., an innovative molecular diagnostics company that has developed the new gold standard in carrier screening, today announced that it has closed a non-dilutive loan facility for up to $28 million of capital from Capital Royalty L.P.

8 May 2013

Kinase inhibitors: an interview with Jan Hoflack, CSO of Oncodesign

Kinase inhibitors are molecules that block the activity of kinases. Kinases are a specific class of enzymes. They are extremely important in signal transduction processes in the human body meaning that they actually regulate most of the physiological processes that take place in the body.

7 May 2013

Aeras receives grant to support the development of vaccines against TB, HIV and malaria

Aeras, a nonprofit biotech advancing TB vaccines for the world, the University of Oxford and Okairos, a biopharmaceutical company specializing in T-cell vaccines, today announced a $2.9 million grant to Aeras in support of a collaboration among the three parties to support the development of vaccines against tuberculosis, HIV and malaria.

7 May 2013

Study: Gene mutations are associated with severe form of nearsightedness

People have long taken for granted that glasses and contact lenses improve vision for nearsightedness, but the genetic factors behind the common condition have remained blurry. Now researchers at Duke Medicine are closer to clearing this up.

3 May 2013

Study brings opportunities of personalised therapy for breast cancer a step closer

A study led by prominent breast cancer experts from Europe and the US has revealed a number of potentially important prospects for targeted therapies, and brings opportunities of truly personalised therapy for breast cancer a step closer, researchers said at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.

2 May 2013

Mayo Clinic researchers identify 27 genes that respond differently to rubella vaccine

Using advanced genetic sequencing technology and analysis, Mayo Clinic vaccine researchers have identified 27 genes that respond in very different ways to the standard rubella vaccine, making the vaccine less effective for a portion of the population.

2 May 2013

Berkeley Lab researchers unveil analytical technique for easy comparisons of proteins in solution

A revolutionary X-ray analytical technique that enables researchers at a glance to identify structural similarities and differences between multiple proteins under a variety of conditions has been developed by researchers with the U.S. Department of Energy's Lawrence Berkeley National Laboratory.

30 Apr 2013

RainDance Technologies announces closing of $20M Series E financing round

RainDance Technologies, Inc., the Digital Biology Company, today announced the closing of a $20 million Series E financing round. The company also announced that Myriad Genetics, Inc. has joined as a new strategic equity investor.

29 Apr 2013

Researchers discover gene that can cause 3 different diseases depending on its alteration

An international research consortium led by the Universitat Aut-noma de Barcelona (UAB), the CIBERER and the University of Wurzburg (Germany) has discovered a gene that can cause three totally different diseases, depending on how it is altered.

26 Apr 2013

Maryland professor to receive Pharmacy Educator Award for outstanding achievements in pharmacy education

The American Association of Colleges of Pharmacy (AACP) will honor Mary Lynn McPherson, PharmD, BCPS, CPE, professor and vice chair for academic affairs in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy, for her excellence as a teacher, her outstanding achievements as a researcher and scholar, and her overall impact on pharmacy education and the profession.

25 Apr 2013

RUSM students to perform clinical training at Vanguard MacNeal Hospital

Ross University School of Medicine announced an agreement with Vanguard MacNeal Hospital in Berwyn, Ill. which enables RUSM students to perform clinical training in the Chicago-area teaching hospital.

23 Apr 2013

OHSU, Intel team up to develop technologies to make personalized genomic analysis faster

Oregon Health & Science University and Intel Corp. are teaming up to develop next-generation computing technologies that advance the field of personalized medicine by dramatically increasing the speed, precision and cost-effectiveness of analyzing a patient's individual genetic profile.

23 Apr 2013

ARCA biopharma, Medtronic to study effectiveness of Gencaro for prevention of atrial fibrillation

ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has entered into an agreement with Medtronic, Inc., a leader in medical technologies to improve the treatment of chronic diseases, including cardiac rhythm disorders, to collaborate on ARCA's proposed clinical trial, known as GENETIC-AF, of its lead developmental drug Gencaro (bucindolol hydrochloride).

From Medtronic 23 Apr 2013

Next Generation News and Research

National Institutes of Health names University of Rochester a Center for AIDS Research

Convergent to discuss ways to enhance patient experience with healthcare leaders

European Patent Office issues notice of intent to grant patent for Nuvo Research's PENNSAID 2%

Columbia Laboratories net revenues increase 65% to $6.3 million in first quarter 2013

CGCF backs Canadian scientist's research on Spinal Muscular Atrophy

Study shows patient selection based on biosamples makes clinical trials more efficient, reduces costs

Elixir Medical receives FDA approval to initiate patient enrollment in EXCELLA III clinical trial in US

Good Start Genetics gets $28M loan from Capital Royalty

Kinase inhibitors: an interview with Jan Hoflack, CSO of Oncodesign

Aeras receives grant to support the development of vaccines against TB, HIV and malaria

Study: Gene mutations are associated with severe form of nearsightedness

Study brings opportunities of personalised therapy for breast cancer a step closer

Mayo Clinic researchers identify 27 genes that respond differently to rubella vaccine

Berkeley Lab researchers unveil analytical technique for easy comparisons of proteins in solution

RainDance Technologies announces closing of $20M Series E financing round

Researchers discover gene that can cause 3 different diseases depending on its alteration

Maryland professor to receive Pharmacy Educator Award for outstanding achievements in pharmacy education

RUSM students to perform clinical training at Vanguard MacNeal Hospital

OHSU, Intel team up to develop technologies to make personalized genomic analysis faster

ARCA biopharma, Medtronic to study effectiveness of Gencaro for prevention of atrial fibrillation

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News